The ESCMID Study Group for Viral Hepatitis (ESGVH) is deeply committed to advancing knowledge on viral hepatitis. Uniting members from all over the globe, they are dedicated to:
Exposure to biological fluids in dental practice – Narrative review on appropriate risk assessment to guide post-exposure management.
Săndulescu M, Nicolescu MI, Funieru C, Şahin GÖ, Săndulescu O and ESCMID Study Group for Viral Hepatitis (ESGVH). Pathogens. 2023;12(7):968.
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.
Said ZNA, El Habashy SA, Zaky S and ESCMID Study Group for Viral Hepatitis (ESGVH). World J Gastroenterol. 2023;29(7):1123–1130.
ESGVH AMM webinar on Atypical serological tests and their interpretation in Hepatitis B Viral infection
19 December 2024, 15:00-16:00 CET
Management of HBV and HCV in transplant patients
9 December 2024, 16:00 CET
Chair: İmran Hasanoglu
Speakers: Harrys Antonio Torres and Paolo Antonio Grossi
ESGVH: Hepatitis C Virus in Special and Vulnerable Populations
25 November 2024, 13:00-14:00 CET
Breaking the Wall on Hepatitis A and E Vaccination: Should we change current recommendations?
18 December 2023
If you have questions or comments for our study group, we warmly invite you to contact us!